MedTrace Logo

The Potential for HPV Self-testing to Promote Participation in Cervical Screening

NCT02779621 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-02-24

No results posted yet for this study

Summary

To explore the potential for vaginal self-sampling to increase participation in cervical screening, we offer the option of self-sampling to a group of non-participants in cervical screening (intervention), in addition to the routine screening (smear) test. Women in the control group will only receive the routine screening invitation letter. The total screening uptake rate, 2 months since the recruitment in each group will be compared.

Conditions

  • Cervix Diseases

Interventions

PROCEDURE

Self-collecting a vaginal sample with a swab for HPV testing

The vaginal sample self-collected with the Floq swab will be tested for Human Papillomavirus (HPV) using Abbott RealTime PCR assay.

PROCEDURE

Collection of cervical sample for routine cervical screening

This is the routine cervical screening test available to the public through the NHS. This sample is collected by a clinician (usually a Practice Nurse)

Sponsors & Collaborators

  • Abbott

    collaborator INDUSTRY

  • Copan Italia SPA , Via F. Perotti, 10, 25125 Brescia, Italy

    collaborator UNKNOWN

  • University Hospitals Coventry and Warwickshire NHS Trust

    lead OTHER

Principal Investigators

  • Ceri Jones · Head of Research, Development & Innovation, UHCW, Coventry

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-01-31
Completion
2017-01-25

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02779621 on ClinicalTrials.gov